Israeli biomed company V-Wave, which developed a medical instrument for treating congestive heart failure, has announced the closing of a successful financing round, raising $2 million.
The financing round comes after a reported successful animal trial of the instrument and will be used towards promoting human trials.
Subscribe to NoCamels weekly newsletter and get our top stories
Facebook comments